Stockreport

Immunomedics' trodelvy shows 27% response rate in urothelial cancer [Seeking Alpha]

IMMUNOMEDICS  (IMMU) 
Last immunomedics earnings: 2/27 04:00 pm Check Earnings Report
PDF HealthcareImmunomedics' trodelvy shows 27% response rate in urothelial cancerSep. 21, 2020 9:05 AM ET|Immunomedics, Inc. (IMMU)Vandana Singh(NASDAQ:announced positiveRe [Read more]